PMGC HOLDINGS INC. Increase (Decrease) in Receivables
PMGC HOLDINGS INC. (ELAB) reported Increase (Decrease) in Receivables of -$529.96 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2026-08-14
- PMGC HOLDINGS INC. increase (decrease) in receivables for the quarter ending 2026-06-30 was -$409.91K, a 1573.80% decline year-over-year.
- PMGC HOLDINGS INC. increase (decrease) in receivables for the quarter ending 2026-03-31 was -$120.05K, a 256.60% decline year-over-year.
- PMGC HOLDINGS INC. increase (decrease) in receivables for the quarter ending 2025-12-31 was $18.78K, a 11.55% decline year-over-year.
- PMGC HOLDINGS INC. increase (decrease) in receivables for the quarter ending 2025-09-30 was -$22.66K.
- PMGC HOLDINGS INC. increase (decrease) in receivables for fiscal 2025 was $100.59K, a 675.65% increase from fiscal 2024.
- PMGC HOLDINGS INC. increase (decrease) in receivables for fiscal 2024 was $12.97K, a 44.14% decline from fiscal 2023.
- PMGC HOLDINGS INC. increase (decrease) in receivables for fiscal 2023 was $23.22K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$409.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$529.96K 10-Q · filed 2026-08-14 | -$511.18K derived: sum of 3 quarters · filed 2026-08-14 | -$533.84K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$120.05K 10-Q · filed 2026-05-15 | -$101.27K derived: sum of 2 quarters · filed 2026-05-15 | -$123.93K derived: sum of 3 quarters · filed 2026-05-15 | -$96.11K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $18.78K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$3.88K derived: sum of 2 quarters · filed 2026-03-30 | $23.93K derived: sum of 3 quarters · filed 2026-08-14 | $100.59K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$22.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $5.15K derived: sum of 2 quarters · filed 2026-08-14 | $81.81K 10-Q · filed 2025-11-14 | $103.05K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $27.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $104.47K 10-Q · filed 2026-08-14 | $125.71K derived: sum of 3 quarters · filed 2026-08-14 | $124.40K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $76.66K 10-Q · filed 2026-05-15 | $97.89K derived: sum of 2 quarters · filed 2026-05-15 | $96.59K derived: sum of 3 quarters · filed 2026-05-15 | $71.51K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $21.23K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $19.93K derived: sum of 2 quarters · filed 2026-03-30 | -$5.15K derived: sum of 3 quarters · filed 2026-03-30 | $12.97K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$1.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$26.39K derived: sum of 2 quarters · filed 2025-11-14 | -$8.27K 10-Q · filed 2025-11-14 | $19.46K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$25.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$6.96K 10-Q · filed 2025-08-13 | $20.77K derived: sum of 3 quarters · filed 2025-08-13 | -$5.22K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $18.12K 10-Q · filed 2025-05-14 | $45.84K derived: sum of 2 quarters · filed 2025-05-14 | $19.86K derived: sum of 3 quarters · filed 2025-05-14 | $8.08K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $27.73K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $1.74K derived: sum of 2 quarters · filed 2025-03-28 | -$10.04K derived: sum of 3 quarters · filed 2025-03-28 | $23.22K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$25.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$37.76K derived: sum of 2 quarters · filed 2024-11-14 | -$4.51K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$11.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $21.48K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $33.25K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |